CIK 0000921299
- Non-accelerated filer
- Smaller reporting company
KYNTRA BIO, INC.
Sign in to watch- Ticker
- KYNB
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- Operating
- EIN
- 770357827
- Phone
- +1 415-978-1200
- Business address
- 350 BAY STREET, SUITE 100 #6009, SAN FRANCISCO, CA, 94133
- Former names
- FIBROGEN INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2019-11-14 | Chung Christine SVP, China Operations | Exercise or conversion · Stock Option (Right to Buy) | −3,334 | 25,000 | ||
| 2019-11-14 | Chung Christine SVP, China Operations | Exercise or conversion · Stock Option (Right to Buy) | −2,291 | 72,709 | ||
| 2019-11-13 | Chung Christine SVP, China Operations | Exercise or conversion | +5,625 | $19.39 | $109K | 145,253 |
| 2019-11-13 | Chung Christine SVP, China Operations | Sale | −5,625 | $34.54 | $194K | 139,628 |
| 2019-11-13 | Chung Christine SVP, China Operations | Exercise or conversion · Stock Option (Right to Buy) | −5,625 | 28,334 | ||
| 2019-11-08 | Cotroneo Pat SVP, Finance and CFO | Exercise or conversion | +12,500 | $2.90 | $36K | 256,932 |
| 2019-11-08 | Cotroneo Pat SVP, Finance and CFO | Exercise or conversion · Stock Option (Right to Buy) | −12,500 | 0 | ||
| 2019-11-07 | Kurkijarvi Kalevi Director | Exercise or conversion | +6,000 | $9.78 | $59K | 34,400 |
| 2019-11-07 | Kurkijarvi Kalevi Director | Sale | −4,514 | $38.08 | $172K | 29,886 |
| 2019-11-07 | Kurkijarvi Kalevi Director | Sale | −1,486 | $38.85 | $58K | 28,400 |
| 2019-11-07 | Kurkijarvi Kalevi Director | Exercise or conversion · Stock Option (Right to Buy) | −6,000 | 0 | ||
| 2019-10-09 | Chung Christine SVP, China Operations | Exercise or conversion | +5,625 | $19.39 | $109K | 145,253 |
| 2019-10-09 | Chung Christine SVP, China Operations | Sale | −5,625 | $36.58 | $206K | 139,628 |
| 2019-10-09 | Chung Christine SVP, China Operations | Exercise or conversion · Stock Option (Right to Buy) | −5,625 | 33,959 | ||
| 2019-10-08 | Chung Christine SVP, China Operations | Exercise or conversion | +5,625 | $19.39 | $109K | 145,253 |
| 2019-10-08 | Chung Christine SVP, China Operations | Sale | −3,225 | $36.55 | $118K | 142,028 |
| 2019-10-08 | Chung Christine SVP, China Operations | Sale | −2,400 | $37.10 | $89K | 139,628 |
| 2019-10-08 | Chung Christine SVP, China Operations | Exercise or conversion · Stock Option (Right to Buy) | −5,625 | 39,584 | ||
| 2019-10-07 | Kurkijarvi Kalevi Director | Exercise or conversion | +6,000 | $9.78 | $59K | 34,400 |
| 2019-10-07 | Kurkijarvi Kalevi Director | Sale | −6,000 | $36.73 | $220K | 28,400 |
Page 26 of 33 · 651 trades